# PCLAF

## Overview
PCLAF, or PCNA clamp associated factor, is a gene that encodes a protein involved in critical cellular processes such as DNA replication and repair. The protein, also referred to as PCLAF, functions primarily within the nucleus and is integral to maintaining genomic stability by interacting with the proliferating cell nuclear antigen (PCNA). This interaction facilitates the recruitment of DNA polymerases and other essential factors necessary for DNA synthesis and repair, particularly during the S phase of the cell cycle. PCLAF's role extends to regulating the cell cycle and ensuring accurate DNA replication, thereby preventing genomic instability and potential mutations that could lead to diseases such as cancer. The protein's involvement in DNA repair further underscores its importance in protecting cells from DNA damage accumulation, contributing to cellular health and genomic integrity (Liu2022PCLAF; Tantiwetrueangdet2021PCNAassociated).

## Structure


## Function
PCLAF (PCNA clamp associated factor) is a protein that plays a critical role in DNA replication and repair processes in healthy human cells. It interacts with the proliferating cell nuclear antigen (PCNA), a key component of the DNA replication machinery, to facilitate the recruitment of DNA polymerases and other essential factors necessary for DNA synthesis and repair. This interaction is crucial during the S phase of the cell cycle, where PCLAF helps ensure the accurate duplication of the genome, thereby maintaining genomic stability.

PCLAF is primarily active in the nucleus, where it contributes to the regulation of the cell cycle. By assisting in the recruitment of DNA polymerases, PCLAF ensures that DNA replication proceeds efficiently and accurately, preventing errors that could lead to genomic instability. This function is vital for the proper progression of the cell cycle and for the prevention of mutations that could potentially lead to diseases such as cancer.

Through its role in DNA repair, PCLAF also helps protect cells from the accumulation of DNA damage, which is essential for maintaining cellular health and function. By supporting these critical molecular processes, PCLAF contributes to the overall stability and integrity of the organism's genome.

## Clinical Significance
Alterations in the expression of the PCLAF gene have significant clinical implications in various cancers. In neuroblastoma, high PCLAF expression is associated with poor prognosis, advanced clinical stages, and increased tumor proliferation. It is particularly overexpressed in high-risk patients and those with MYCN amplification, correlating with worse overall survival and event-free survival (Liu2022PCLAF). In prostate cancer, PCLAF is upregulated in primary tumors and linked to higher Gleason scores and advanced stages. The miR-30a-5p/PCLAF axis plays a crucial role, where miR-30a-5p downregulation leads to increased PCLAF expression, promoting cancer progression (Zhao2019MiR30a5p).

In adrenocortical carcinoma (ACC), PCLAF is identified as a hub gene with significant expression changes, particularly in relation to TP53 mutation status. Its overexpression is associated with a marked decrease in survival rates, highlighting its potential as a prognostic biomarker (Jafari2023Five). In hepatocellular carcinoma (HCC), PCLAF overexpression is linked to poor patient survival, although it is not due to gene amplification (Tantiwetrueangdet2021PCNAassociated). These findings underscore the potential of PCLAF as a target for therapeutic intervention across multiple cancer types.

## Interactions
PCLAF, also known as PCNA clamp-associated factor, interacts with several proteins, playing a significant role in cell cycle regulation and DNA replication. PCLAF binds to proliferating cell nuclear antigen (PCNA), a critical component of the DNA replication machinery. This interaction is facilitated by the PIP-box motif in PCLAF, which is essential for its binding to PCNA (Tantiwetrueangdet2021PCNAassociated). The interaction with PCNA is crucial for PCLAF's role in DNA synthesis and maintenance of DNA methylation, as well as in DNA damage bypass (Tantiwetrueangdet2021PCNAassociated).

PCLAF also interacts with the transcription factor E2F1, influencing the expression of the PTTG1 gene, which is involved in the G1/S cell cycle transition. This interaction is part of the mechanism by which PCLAF regulates cell proliferation in neuroblastoma cells (Liu2022PCLAF).

In the context of lung tumorigenesis, PCLAF interacts with RBBP4, a component of the MuvB core in the DREAM complex. This interaction antagonizes the formation of the repressive DREAM complex, thereby promoting cell proliferation by preventing the recruitment of p130, a component of the complex (Kim2021PAF). These interactions highlight PCLAF's multifaceted role in regulating cell cycle progression and proliferation.


## References


[1. (Zhao2019MiR30a5p) Hu Zhao, Wei Zhang, Xiaofeng Lai, Hehuan Zhu, Shenhang Zhang, Weizhen Wu, Shuiliang Wang, Minying Tang, Zhen Deng, and Jianming Tan. Mir-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting pclaf. Artificial Cells, Nanomedicine, and Biotechnology, 47(1):278â€“289, January 2019. URL: http://dx.doi.org/10.1080/21691401.2018.1553783, doi:10.1080/21691401.2018.1553783. This article has 30 citations.](https://doi.org/10.1080/21691401.2018.1553783)

[2. (Tantiwetrueangdet2021PCNAassociated) Anchalee Tantiwetrueangdet, Ravat Panvichian, Pattana Sornmayura, Surasak Leelaudomlipi, and Jill A. Macoska. Pcna-associated factor (kiaa0101/pclaf) overexpression and gene copy number alterations in hepatocellular carcinoma tissues. BMC Cancer, March 2021. URL: http://dx.doi.org/10.1186/s12885-021-07994-3, doi:10.1186/s12885-021-07994-3. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-021-07994-3)

3. (Jafari2023Five) Five new hub genes that have an impact on the survival rate of adrenocortical carcinoma were discovered using a correlation network approach in a comprehensive meta-analysis. This article has 0 citations.

[4. (Kim2021PAF) Moon Jong Kim, Christopher Cervantes, Youn-Sang Jung, Xiaoshan Zhang, Jie Zhang, Sung Ho Lee, Sohee Jun, Larisa Litovchick, Wenqi Wang, Junjie Chen, Bingliang Fang, and Jae-Il Park. Paf remodels the dream complex to bypass cell quiescence and promote lung tumorigenesis. Molecular Cell, 81(8):1698-1714.e6, April 2021. URL: http://dx.doi.org/10.1016/j.molcel.2021.02.001, doi:10.1016/j.molcel.2021.02.001. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2021.02.001)

[5. (Liu2022PCLAF) Xiaowei Liu, Yuanxia Cai, Cheng Cheng, Yaoyao Gu, Xiaoxiao Hu, Kai Chen, Yeming Wu, and Zhixiang Wu. Pclaf promotes neuroblastoma g1/s cell cycle progression via the e2f1/pttg1 axis. Cell Death &amp; Disease, February 2022. URL: http://dx.doi.org/10.1038/s41419-022-04635-w, doi:10.1038/s41419-022-04635-w. This article has 18 citations.](https://doi.org/10.1038/s41419-022-04635-w)